首页 | 本学科首页   官方微博 | 高级检索  
检索        

氩氦冷冻消融治疗进展期肝癌的疗效及其影响因素研究
引用本文:常秀娟,陆荫英,白文林,陈艳,安林静,周霖,吴煜,王鋐,楼敏,苏淑慧,杨永平.氩氦冷冻消融治疗进展期肝癌的疗效及其影响因素研究[J].肝脏,2010,15(1):11-14.
作者姓名:常秀娟  陆荫英  白文林  陈艳  安林静  周霖  吴煜  王鋐  楼敏  苏淑慧  杨永平
作者单位:1. 100039,北京,解放军军事医学科学院;解放军第三○二医院肝癌治疗研究中心
2. 解放军第三○二医院肝癌治疗研究中心
基金项目:国家重大专项基金资助项目,军队医学杰出人才基金资助项目 
摘    要:目的探讨氩氦冷冻消融治疗乙型肝炎相关性进展期肝细胞癌(HCC)的临床疗效和影响生存期的因素。方法采用临床列队对照研究190例乙型肝炎相关性进展期HCC患者,其中147例行氩氦冷冻消融治疗,43例未行局部消融和肝动脉化疗栓塞治疗。结果氩氦冷冻消融乙型肝炎相关性进展期HCC患者生存期为10.11个月,未治疗者生存期仅为4.73个月,氩氦冷冻消融治疗进展期HCC严重肝损伤发生率为5.4%,Child-Pugh分级≥B8的病例占87.5%,胆红素水平51.3μmol/L者占75%;在HBV相关性进展期HCC中,HBV DNA载量中、低水平占91%,HBeAg阴性患者占66.67%,两者与肿瘤细胞分化程度无关;肝硬化程度及肿瘤细胞分化程度是影响进展期HCC患者生存期的关键因素。结论冷冻消融治疗乙型肝炎相关性进展期HCC能显著延长患者的生存期,是影响进展期HCC生存期的独立因素;Child-Pugh分级≥B8,伴有胆红素水平51.3μmol/L的进展期HCC患者不适宜行冷冻消融;肝硬化程度及肿瘤细胞分化程度是影响进展期HCC患者生存期的关键因素。

关 键 词:氩氦冷冻消融  慢性乙型肝炎  进展期肝细胞癌  生存期

Clinical effect and survival time of argon-helium cryoablation for hepatitis B-related advanced hepatocellular carcinoma:a pilot clinical study
CHANG Xiu-juan,LU Yin-ying,BAI Wen-lin,CHEN Yan,AN Lin-jing,ZHOU Lin,WU Yu,WANG Hong,LOU Min,SU Shu-hui,YANG Yong-ping.Clinical effect and survival time of argon-helium cryoablation for hepatitis B-related advanced hepatocellular carcinoma:a pilot clinical study[J].Chinese Hepatology,2010,15(1):11-14.
Authors:CHANG Xiu-juan  LU Yin-ying  BAI Wen-lin  CHEN Yan  AN Lin-jing  ZHOU Lin  WU Yu  WANG Hong  LOU Min  SU Shu-hui  YANG Yong-ping
Institution:CHANG Xiu-juan,LU Yin-ying,BAI Wen-lin,CHEN Yan,AN Lin-jing,ZHOU Lin,WU Yu,WANG Hong,LOU Min,SU Shu-hui,YANG Yong-ping.Center of Therapeutic Research for Hepatocellular Carcinoma,302 Hospital of PLA,Beijing 100039,China
Abstract:Objective To evaluate the clinical effect and the survival time of percutaneous argon-helium cryoablation for hepatitis B-related advanced hepatocellular cancer.Methods One hundred and ninty patients(147 patients with cryoablated,43 patients without any ablation) with hepatitis B-related HCC were studied by means of clinical cohort.Results The survival time of patients with hepatitis B-related advanced HCC received cryoablation was 10.11 months.On the contrary the survival time was 4.73 months.The rate of t...
Keywords:Cryoablation  Chronic hepatitis B  Advance hepatocellular carcinoma  Over of survivial time  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号